BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37191462)

  • 21. Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
    Stoyanova R; Hachem P; Hensley H; Khor LY; Mu Z; Hammond ME; Agrawal S; Pollack A
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1151-60. PubMed ID: 17637390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-guided Focused Ultrasound Facilitates Sonodynamic Therapy with 5-Aminolevulinic Acid in a Rat Glioma Model.
    Wu SK; Santos MA; Marcus SL; Hynynen K
    Sci Rep; 2019 Jul; 9(1):10465. PubMed ID: 31320671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
    Udayakumar TS; Stoyanova R; Hachem P; Ahmed MM; Pollack A
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):549-58. PubMed ID: 21195876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.
    Kestin LL; Goldstein NS; Vicini FA; Mitchell C; Gustafson GS; Stromberg JS; Chen PY; Martinez AA
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):107-18. PubMed ID: 12182980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion Tensor Imaging and Chemical Exchange Saturation Transfer MRI Evaluation on the Long-Term Effects of Pulsed Focused Ultrasound and Microbubbles Blood Brain Barrier Opening in the Rat.
    Tu TW; Kovacs ZI; Sundby M; Witko JA; Papadakis GZ; Reid WC; Hammoud DA; Frank JA
    Front Neurosci; 2020; 14():908. PubMed ID: 32982680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis.
    Burks SR; Nagle ME; Bresler MN; Kim SJ; Star RA; Frank JA
    J Cell Mol Med; 2018 Dec; 22(12):6015-6025. PubMed ID: 30216653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR-guided pulsed focused ultrasound improves mesenchymal stromal cell homing to the myocardium.
    Jang KW; Tu TW; Rosenblatt RB; Burks SR; Frank JA
    J Cell Mol Med; 2020 Nov; 24(22):13278-13288. PubMed ID: 33067927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curvilinear transurethral ultrasound applicator for selective prostate thermal therapy.
    Ross AB; Diederich CJ; Nau WH; Rieke V; Butts RK; Sommer G; Gill H; Bouley DM
    Med Phys; 2005 Jun; 32(6):1555-65. PubMed ID: 16013714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-1 as a biomarker to predict therapeutic effect of low-frequency ultrasound combined with SonoVue on prostate cancer in nude mice model.
    Xu W; Nan S; Bai W; Shen E; Hu B
    Cancer Biomark; 2014; 14(4):279-86. PubMed ID: 24934371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR-guided focused ultrasound: enhancement of intratumoral uptake of [³H]-docetaxel in vivo.
    Chen L; Mu Z; Hachem P; Ma CM; Wallentine A; Pollack A
    Phys Med Biol; 2010 Dec; 55(24):7399-410. PubMed ID: 21098923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-Use Transducer for Ultrasound Imaging and Pulsed Focused Ultrasound Therapy.
    Karzova MM; Yuldashev PV; Khokhlova VA; Nartov FA; Morrison KP; Khokhlova TD
    IEEE Trans Ultrason Ferroelectr Freq Control; 2021 Sep; 68(9):2930-2941. PubMed ID: 33793399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salicylate enhances the response of prostate cancer to radiotherapy.
    Broadfield LA; Marcinko K; Tsakiridis E; Zacharidis PG; Villani L; Lally JSV; Menjolian G; Maharaj D; Mathurin T; Smoke M; Farrell T; Muti P; Steinberg GR; Tsakiridis T
    Prostate; 2019 Apr; 79(5):489-497. PubMed ID: 30609074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Metabolic and Perfusion Imaging Using Hyperpolarized
    Qin H; Zhang V; Bok RA; Santos RD; Cunha JA; Hsu IC; Santos Bs JD; Lee JE; Sukumar S; Larson PEZ; Vigneron DB; Wilson DM; Sriram R; Kurhanewicz J
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):887-896. PubMed ID: 32339646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle.
    Tebebi PA; Burks SR; Kim SJ; Williams RA; Nguyen BA; Venkatesh P; Frenkel V; Frank JA
    Stem Cells; 2015 Apr; 33(4):1173-86. PubMed ID: 25534849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation.
    McNabb E; Al-Mahrouki A; Law N; McKay S; Tarapacki C; Hussein F; Czarnota GJ
    PLoS One; 2020; 15(9):e0239456. PubMed ID: 32976517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage.
    Zhang X; Bobeica M; Unger M; Bednarz A; Gerold B; Patties I; Melzer A; Landgraf L
    Strahlenther Onkol; 2021 Aug; 197(8):730-743. PubMed ID: 33885910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.
    Cowen D; Salem N; Ashoori F; Meyn R; Meistrich ML; Roth JA; Pollack A
    Clin Cancer Res; 2000 Nov; 6(11):4402-8. PubMed ID: 11106260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer in vivo.
    Panetta JV; Cvetkovic D; Chen X; Chen L; Ma CC
    Phys Med Biol; 2020 Aug; 65(16):165008. PubMed ID: 32464613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts.
    Hagtvet E; Røe K; Olsen DR
    Radiat Oncol; 2011 Oct; 6():135. PubMed ID: 21981945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response.
    Cohen G; Chandran P; Lorsung RM; Tomlinson LE; Sundby M; Burks SR; Frank JA
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.